TY  - JOUR
AU  - Padrón-Barthe, Laura
AU  - Gómez-Salinero, Jesús M.
AU  - Domínguez, Fernando
AU  - Román, Marta
AU  - Larrasa-Alonso, Javier
AU  - Martínez, Fernando
AU  - López-Olañeta, Marina
AU  - Bonzón-Kulichenko, Elena
AU  - Vázquez, Jesús
AU  - Martí-Gómez, Carlos
AU  - Santiago,  Demetrio J.
AU  - Prados, Belén
AU  - Giovinazzo, Giovanna
AU  - Gómez-Gaviro, María Victoria
AU  - Priori, Silvia
AU  - Garcia-Pavia, Pablo
AU  - Lara-Pezzi, Enrique
AU  - Villalba Orero, María
AU  - Ortiz Sánchez, Paula
PY  - 2019
DO  - 10.1161/circulationaha.119.040366
SN  - 0009-7322
SN  - 1524-4539
UR  - https://hdl.handle.net/20.500.14352/95164
T2  - Circulation
AB  - BACKGROUND: Arrhythmogenic cardiomyopathy/arrhythmogenic right ventricular cardiomyopathy (ARVC) is an inherited cardiac disease characterized by fibrofatty replacement of the myocardium, resulting in heart failure and sudden cardiac death. The most...
LA  - eng
M2  - 1188
PB  - American Heart Association
KW  - arrhythmogenic right ventricular dysplasia
KW  - calcineurin
KW  - GSK3β
KW  - therapy
KW  - TMEM43
TI  - Severe Cardiac Dysfunction and Death Caused by Arrhythmogenic Right Ventricular Cardiomyopathy Type 5 Are Improved by Inhibition of Glycogen Synthase Kinase-3β
TY  - journal article
VL  - 140
ER  -